| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |